ArticlePerioperative medicine (London, England)2026
Stellate ganglion block for attenuating postoperative sore throat after double-lumen tube intubation in thoracic surgery: a randomized clinical study.
Article in Perioperative medicine (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundFor thoracic surgery patients who undergo double-lumen endotracheal intubation, postoperative sore throat (POST) remains one of the most common postoperative complication.
objectiveTo evaluate whether preoperative ultrasound-guided stellate ganglion block (SGB) can reduce the incidence and severity of POST, and decrease the postoperative throat VAS score in patients undergoing double-lumen tube (DLT) intubation for thoracic surgery.
methodsThis prospective, randomized, double-blind, controlled clinical trial enrolled 120 patients undergoing elective thoracic surgery with DLT intubation. Participants were randomized into two groups: the SGB group (n = 60) received 2-3 ml of 0.25% ropivacaine under ultrasound guidance on the right stellate ganglion, while the control group (n = 60) received no regional anesthetic intervention prior to anesthesia induction. The primary outcomes included the incidence and severity of POST and the visual analogue scale (VAS) scores for throat pain. Secondary outcomes included the incidence of postoperative hoarseness, cough, and postoperative pulmonary complications (PPCs), as well as the levels of serum inflammatory markers before and 1 day after surgery.
resultsThe incidence of POST was significantly lower in the SGB group at 1 h, 6 h, and 24 h postoperatively compared to the control group (10.3%, 13.8%, and 5.2% vs. 44.1%, 35.6%, and 20.3%, respectively, p < 0.05). The severity grading of POST in the SGB group was also lower than that in the control group at all three time points (p < 0.05). Additionally, the throat VAS scores in the SGB group at 1 h and 6 h postoperatively (0.45 ± 1.45 and 0.34 ± 1.05, respectively) were significantly lower than those in the control group (1.88 ± 2.54 and 0.93 ± 1.41, respectively; p < 0.05). Cough incidence was significantly lower in the SGB group at 1 h and 6 h (both 5.2%) than in the control group (both 20.3%, P = 0.014).
conclusionsPreoperative ultrasound-guided SGB significantly alleviates POST and reduces the early postoperative cough incidence in thoracic surgery patients undergoing DLT intubation.
trial registrationThe study was registered on Chinese Clinical Trial Registry, (ChiCTR2500106117) on 17/07/2025.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.